Bristol Heart Institute
Bristol, Avon, BS2 8HW, United Kingdom
NCT Number: NCT01897350
Cardiac magnetic resonance imaging (CMR) is a non invasive technique used to obtain functional and anatomical information on the heart. Several CMR parameters measured after primary percutaneous coronary intervention (PPCI) have been shown to have prognostic value and are increasingly being used as surrogate endpoints in clinical trials. Myocardial oedema is a prognostic indicator following myocardial infarction1. Myocardial salvage is calculated as the myocardial oedema minus infarct size; this again is a prognostic indicator following STEMI. However, myocardial oedema imaging is controversial. There are multiple sequences available, with no standardisation of sequences used to assess this surrogate endpoint. The investigators propose to conduct a study to measure the myocardial oedema by all available techniques to determine the agreement between these methods.
Looking for future studies?
Notify Me18 year–85 year
All sexes
Observational
Bristol, Avon, BS2 8HW, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 2 following STEMI
Time frame: Day 2 following STEMI
Elisa McAlindon
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03508232
Cardiovascular Diseases, Heart Diseases
Edmonton, Alberta, Canada
View Trial DetailsNCT05461781
Arterial Occlusive Diseases, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT05705089
Cardiovascular Diseases, Embolism and Thrombosis
Tehran, Iran
View Trial DetailsNCT01538303
Cardiovascular Diseases, Heart Diseases
Eindhoven, North Brabant, Netherlands
View Trial Details